Penn State researchers use immune cells to deliver cancer drugs

Researchers from the Penn State Materials Research Institute have developed a biodegradable and photoluminescent nanoparticle that are carried by immune cells to target melanoma. The team’s work was published last week in the journal Small. 

“The traditional way to deliver drugs to tumors is to put the drug inside some type of nanoparticle and inject those particles into the bloodstream,” co-senior author Jian Yang said in prepared remarks. “Because the particles are so small, if they happen to reach the tumor site they have a chance of penetrating through the blood vessel wall because the vasculature of tumors is usually leaky.”

Get the full story at our sister site, Drug Delivery Business News.

The post Penn State researchers use immune cells to deliver cancer drugs appeared first on MassDevice.

from MassDevice http://ift.tt/2hTxQqx